Top Stories
A smart phone on a desk with Anthropic's Claude logo on the screen

Anthropic confidentially files for IPO: Here's what it means

Anthropic announced today that it had " confidentially submitted a draft registration statement on Form S-1 to the U.S. Securities and Exchange Commission for a proposed initial public offering of our common stock." An S-1 is the registration document a company files with regulators before it

A picture inside an empty theatre in Netflix's Tokyo office with Netflix logo on the screen

Netflix Stock Price Soars After Earnings Report Record New Memberships

Netflix stock price ( NASDAQ: NFLX ) is up more than 13% in the after-hours following its release of the fourth-quarter earnings report for fiscal year 2024. The streaming company recorded a 16% increase in revenue year-over-year, reaching 19% on a foreign exchange (F/X) neutral basis, which the

Latest News

Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism

GlobeNewswire Inc.

Multi-organ system and quality-of-life benefits sustained through three and a half years 86% response rate for the multi-component endpoint 89% of patients completed the three-and-a-half-year trial COPENHAGEN, Denmark, June 13, 2026 (GLOBE NEWSWIRE)

Richard Roths Media Announces $52 Million Dollar Investment Approval to Expand its AI-Driven Marketing Systems

Newsfile

Richard Roths Media confirms a $52 million investment from GGC Capital Investment Group to expand its AI-driven marketing system for high-trust industries, according to Richard Rothschild, Founder and CEO of Richard Roth's Media.Beverly Hills, Califo

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease

GlobeNewswire Inc.

Mitapivat demonstrated statistically significant improvement in hemoglobin response compared with placebo, with rapid onset and durable effectsNew analyses showed patients in mitapivat arm had clinically meaningful reduction in transfusion burden com

AD

 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026

GlobeNewswire Inc.

-- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or BMI z-score reductions, reductions in fat mass with preservation of lean mass, and improvements in hyperphagia and anxiety measures -- -- Positive re

Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

GlobeNewswire Inc.

Data from HAELO Phase 3 clinical trial presented today in a late-breaking oral session at European Academy of Allergy & Clinical Immunology Annual Congress 2026HAELO manuscript simultaneously published in the New England Journal of Medicine CAMBRIDGE

1win VIP Community Member Ilia Topuria Sets for Historic UFC Freedom 250 Main Event

Newsfile

Mexico City, Mexico--(Newsfile Corp. - June 13, 2026) - As UFC lightweight champion Ilia Topuria prepares for one of the biggest fights of his career, international brand 1win highlights the recent acceptance of the undefeated MMA superstar to the 1w

Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

GlobeNewswire Inc.

DALLAS, June 12, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, announced today the closing of its previously announced private placement priced at-the-market under Nasdaq

Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1

GlobeNewswire Inc.

SAN DIEGO, June 12, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have signific

NU E Power Corp. Files 2026 First Quarter Results

Newsfile

Calgary, Alberta--(Newsfile Corp. - June 12, 2026) - NU E Power Corp. (CSE: NUE) ("NUE" or the "Company") announces that it has filed its unaudited interim condensed consolidated financial statements and management's discussion and analysis ("MD&A")

CleanTech Issues Clarification Regarding Qualified Person Disclosure

Newsfile

Vancouver, British Columbia--(Newsfile Corp. - June 12, 2026) - CleanTech Vanadium Mining Corp. (TSXV: CTV) (OTCQB: CTVFF) ("CleanTech" or the "Company") wishes to clarify that the Qualified Person disclosure contained in its news release dated June

AD